- Home
- IHT vs CRIS Comparison
IHT vs CRIS Comparison
Compare IHT & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IHT | CRIS |
|---|---|---|
| Founded | 1971 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.8M | 12.9M |
| IPO Year | 1995 | 2000 |
Fundamental Metrics
Financial Performance| Metric | IHT | CRIS |
|---|---|---|
| Price | $1.10 | $1.10 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $16.50 |
| AVG Volume (30 Days) | 11.9K | ★ 198.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 1.92% | N/A |
| EPS Growth | N/A | ★ 23.21 |
| EPS | ★ N/A | N/A |
| Revenue | $7,600,000.00 | ★ $9,898,000.00 |
| Revenue This Year | N/A | $6.13 |
| Revenue Next Year | N/A | $7.86 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 1.33 | ★ 31.50 |
| 52 Week Low | $0.95 | $0.77 |
| 52 Week High | $4.24 | $3.18 |
Technical Indicators
Market Signals| Indicator | IHT | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 40.54 | 54.76 |
| Support Level | $1.05 | $1.06 |
| Resistance Level | $1.27 | $1.21 |
| Average True Range (ATR) | 0.08 | 0.09 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 46.88 | 53.83 |
Price Performance
Historical ComparisonAbout IHT InnSuites Hospitality Trust Shares of Beneficial Interest
InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties. It owns and operates hotels, provides management services for hotels, and also provides trademark license services. The Trust is also involved in various operations incidental to the operation of hotels, such as the operation of restaurants, meeting/banquet room rentals, and the operation of a reservation system. It has one reportable segment Hotel Operations & Hotel Management Services.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.